{"id":1004845,"date":"2026-06-16T23:51:16","date_gmt":"2026-06-16T23:51:16","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/1004845\/"},"modified":"2026-06-16T23:51:16","modified_gmt":"2026-06-16T23:51:16","slug":"premiere-bronchoscopie-robotisee-au-chu-de-rouen-une-avancee-majeure-contre-le-cancer-du-poumon","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/1004845\/","title":{"rendered":"Premi\u00e8re bronchoscopie robotis\u00e9e au CHU de Rouen : une avanc\u00e9e majeure contre le cancer du poumon"},"content":{"rendered":"<p>\t\t\t\t\t Chaque ann\u00e9e, pr\u00e8s de 53 000 nouveaux cas de cancer du poumon sont diagnostiqu\u00e9s en France et plus de 30 000 personnes en d\u00e9c\u00e8dent. Malgr\u00e9 les progr\u00e8s th\u00e9rapeutiques, la maladie reste souvent d\u00e9tect\u00e9e \u00e0 un stade avanc\u00e9 en raison de sympt\u00f4mes peu sp\u00e9cifiques. <\/p>\n<p>Le taux de survie \u00e0 cinq ans demeure limit\u00e9 \u00e0 environ 20 %, ce qui renforce l\u2019importance du d\u00e9pistage et d\u2019un diagnostic le plus pr\u00e9coce possible. Les femmes sont particuli\u00e8rement concern\u00e9es, avec une hausse continue de l\u2019incidence observ\u00e9e ces derni\u00e8res ann\u00e9es. <\/p>\n<p>Dans ce contexte, l\u2019Institut national du cancer a lanc\u00e9 le programme pilote \u00ab Impulsion \u00bb, destin\u00e9 \u00e0 \u00e9valuer les modalit\u00e9s d\u2019un d\u00e9pistage organis\u00e9 des cancers du poumon. Les \u00e9tudes sugg\u00e8rent qu\u2019une telle strat\u00e9gie pourrait r\u00e9duire de 20 \u00e0 25 % la mortalit\u00e9 li\u00e9e \u00e0 cette pathologie.\n\t\t\t\t <\/p>\n","protected":false},"excerpt":{"rendered":"Chaque ann\u00e9e, pr\u00e8s de 53 000 nouveaux cas de cancer du poumon sont diagnostiqu\u00e9s en France et plus&hellip;\n","protected":false},"author":2,"featured_media":1004846,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[9587],"tags":[1111,11,101,85427,1777,674,1011,27,224,12,5161,21799,25,9590,71,5163],"class_list":["post-1004845","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rouen","tag-actu","tag-actualites","tag-cancer","tag-chu-charles-nicolle","tag-eu","tag-europe","tag-fr","tag-france","tag-medecine","tag-news","tag-normandie","tag-poumon","tag-republique-francaise","tag-rouen","tag-sante","tag-seine-maritime"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/116762475712905850","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/1004845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=1004845"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/1004845\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/1004846"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=1004845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=1004845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=1004845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}